Navigation Links
Janssen Launches Online Healthy Minds Video Series

TITUSVILLE, N.J., Aug. 5, 2014 /PRNewswire/ -- Janssen Research & Development, LLC, today launched the first in a series of online videos addressing key mental health topics and treatments for disorders of the brain. The five-video Healthy Minds series discusses progress made in brain research and treatment and offers insights for people living with mental illness, as well as those closest to them.

Featured in the video series is Dr. Husseini Manji, a psychiatrist and neuroscientist, and Global Therapeutic Area Head for Neuroscience at Janssen Research & Development. Throughout the series, Dr. Manji shares his expertise on brain health and disorders that affect the brain, discussing the prevalence, projected burden, societal impact, and new trends in research and treatment for Alzheimer's disease, major depression, schizophrenia and bipolar disorder. The Healthy Minds video series is hosted by Emmy Award-winning broadcast journalist Vicki Mabrey.

Across the globe, approximately 450 million people suffer from a mental or neurological disorder, yet nearly 60 percent who have a known disorder never consult a doctor to better understand their mental health. Lack of awareness and stigma are frequently noted as the reasons those suffering do not seek help. The video series aims to assist in familiarizing these disorders with viewers and reducing the stigma associated with them.

"Brain disorders can be devastating for patients, families and society, and despite progress in research and new treatments, the biological nature of these illnesses and how to manage them often are not fully understood," said Seema Kumar, Vice President, Enterprise Innovation, Public Affairs and Global Health Communication, Johnson & Johnson. "The Healthy Minds video series will help to expand education about brain disorders, and in turn, fight the stigma frequently related to them."

The first video, A Discussion about Brain Health, is available today on the Johnson & Johnson YouTube channel and the J&J Corporate Blog. Subsequent videos in the series will be released on a monthly basis throughout the remainder of 2014:

  • Bipolar Disorder – September
  • Major Depressive Disorder – October
  • Alzheimer's Disease – November
  • Schizophrenia - December

Janssen's mental health video series is part of the company's Healthy Minds initiative, dedicated to advancing neuroscience research, news and information regarding mental health. The video project serves as a platform to continue Janssen's leadership and innovation in neuroscience, mental health education, public health and advocacy.

About Janssen Research & Development, LLC
At Janssen, we are dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Driven by our commitment to patients, we develop innovative products, services and healthcare solutions to help people throughout the world. Janssen Research & Development is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit for more information.

About Janssen's Healthy Minds Program
Janssen's interests in integrated care for brain diseases have a direct connection to the Janssen Healthy Minds program, launched in 2011 to encourage collaboration among biotechnology, pharmaceutical and public-sector organizations to accelerate the discovery of new therapeutic solutions for neurologic and brain diseases. Healthy Minds builds on Janssen's longstanding legacy of achievement in advancing neuroscience research. The company's work in this area dates back to the 1950s, when Dr. Paul Janssen's discovery and development work led to one of the first breakthrough treatments for schizophrenia. Janssen takes its name from "Dr. Paul," who is known as one of the 20th century's most gifted and passionate physicians and pharmaceutical researchers.

Over the last half century, Janssen has discovered, developed and launched many innovative treatments for brain and CNS conditions and remains firmly committed to neuroscience. Janssen supports public and professional education about mental illness and brain disorders, and funds sponsorships and philanthropy in the field of neuroscience and mental health.

Greg Panico
Janssen Research & Development, LLC
(609) 730-3061

Video -

SOURCE Janssen Research & Development, LLC
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Janssen Pharmaceutical Companies of Johnson & Johnson Submit Citizen Petition to the U.S. FDA Regarding Naming of Biosimilars
2. Janssen, the Pharmaceutical Companies of Johnson & Johnson, Announces First-of-its-Kind Drug Donation Program for HIV Treatment-Experienced Children
3. Current Hepatitis C Virus Regimens to Face Stiff Competition with the Launch of Gileads Sofosbuvir and Janssen/Medivirs Simeprevir
4. In the Psoriasis Drug Market, Continued Uptake of Janssens Stelara and the Launch of Emerging Systemic Therapies Will Drive Sales Growth to Nearly $9.2 Billion in 2022
5. Janssen R&D Ireland Announces Agreement with PATH for Early Development of Rilpivirine in Long-Acting Formulation for Potential Prophylactic Intervention
6. Among the Novel Oral Anticoagulants, Bayer/Janssens Xarelto is Positioned To Be the Sales-Leading Therapy for Venous Thromboembolism (VTE)
7. Janssen Therapeutics Announces Recipient of Its Second Point Scholarship for LGBT Students
8. Second Genome Announces Agreement with Janssen on Microbiome Drug Discovery in Ulcerative Colitis
9. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
10. Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
11. Findings from Two Phase 3 Studies of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Genotype 1 Chronic Hepatitis C Patients
Post Your Comments:
(Date:11/29/2015)... , Nov. 29, 2015  Strengthening its leadership ... PHG, AEX: PHIA) today announced IntelliSpace Portal 8.0 ... analytics and visualization platform that helps radiologists detect, diagnose ... 2015 Radiological Society of North America Annual Meeting ... IntelliSpace Portal 8.0 helps address the changing demands in ...
(Date:11/29/2015)... , Nov. 29, 2015  At this year,s ... to experience the most complete mobile C-arm portfolio with ... is Ziehm Vision RFD 3D, the world,s only 3D ... edge length per scan volume. In addition, Ziehm Imaging ... motorized mobile C-arm in four axes which is ideally ...
(Date:11/29/2015)... 29, 2015 CIVCO Medical Solutions will ... the Radiological Society of North America ... November 29 – December 4, 2015. ... offer customers unrivaled versatility, enhanced user experience and ... --> ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... International ... UPMC and KingMed Diagnostics researchers. Their review of more ... consultation with UPMC pathologists resulted in significantly altered treatment plans for more than ...
(Date:11/30/2015)... ... November 30, 2015 , ... ”Dying Words: The AIDS Reporting ... on December 1, 2015, to coincide with World AIDS Day. The multi-media project will ... covered the AIDS epidemic as he was dying of the disease. , A collaborative ...
(Date:11/30/2015)... ... November 30, 2015 , ... The Foundation for Breast and ... prevention—is joining forces with the award-winning creator and writer of Downton Abbey Julian ... 2015 at the Union League of Philadelphia. , The benefit, titled “An ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... Ingredients (ASI) as their exclusive channel partner for the Nutraceutical Specialties products into ... in the US, effective immediately. , “We are pleased to announce our ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... Analytics for the last 15 years, announced today that Michigan-based Family Health Center ... of care for over 45 years, FHC was awarded the largest Affordable Care ...
Breaking Medicine News(10 mins):